Deep Track Capital

InvestorActive
Type: Venture FundStage: Series B, Series C+, Series A, Series B+Lead: Leads or followsAUM: ~$5.6BSeries: Fund ILocation: CT, United StatesContinent: North AmericaWebsite

Deep Track Capital is a Greenwich, Connecticut-based investment firm founded in 2020 by David Kroin, former co-founder of Great Point Partners. The firm focuses exclusively on the life sciences industry, investing in both public and pre-IPO biotechnology companies. Its strategy is fundamentally driven and research-intensive, employing a team of healthcare finance professionals with scientific and clinical backgrounds. The firm aims to lead transactions while building large syndicates, and also participates in rounds led by other qualified investors. It manages a reported portfolio value of approximately $5.6 billion in disclosed public and pre-IPO biotech holdings.

Biotech, Life Sciences, Synthetic BiologyHealthcare and Med Tech

Founder Intel

Sign in to read intel from founders who have worked with Deep Track Capital.

What founders say about Deep Track Capital

Be the first to share intel on Deep Track Capital — it's free.

Get Started Free